Recombinant Monoclonal Anti-TROP2 Antibody, Mouse (2A9)

Customer Reviews
Cat. No. / Size
Price
Qty
HCS-S310-20ul
$200.00
HCS-S310-100ul
$500.00
ETA of in-stock products:2 business days

Product Details

  • Background

    Recombinant Monoclonal Anti-TROP2 Antibody, Mouse (2A9) is a TROP2 primary antibody for IHC application. TROP2 is a member of a family including at least two type I membrane proteins. It transduces an intracellular calcium signal and acts as a cell surface receptor.

  • Product Specifications

    Host Species
    Mouse
    Isotype
    IgG
    Clone
    2A9
    Application
    IHC
    Property
    1:1000
    State
    Liquid
    Positive Control
    Human Tonsil Tissue
    Clonality
    Monoclonal
    Research Field
    Cancer Drug Targets
    Source
    Mouse
    Synonym
    TROP2
  • Experiment Protocol

    LEICA Experiment Protocol(Manual)

  • Storage

    Shipped at 4°C. Store at +4°C short term (1-2 weeks). Upon delivery aliquot. Store at -20°C long term. Avoid freeze / thaw cycle. The shelf life is 30 days from the date of opening.

  • ACRO Quality Management System

    1. QMS(ISO, GMP)
    2. Quality Advantages
    3. Quality Control Process

Customers Also Viewed

Performance Data

Typical Data
  • Control Sample

     TROP-2 CONTROL SAMPLE

    Immunohistochemical analysis of paraffin embedded Human Tonsil Tissue labelled with HCS-S310 at 1/1000 dilution.
    Perform heat mediated antigen retrieval with Tris/EDTA buffer pH 9.0 before commencing with IHC staining protocol.

  • Cancer Sample

     TROP-2 CANCER SAMPLE
     TROP-2 CANCER SAMPLE
     TROP-2 CANCER SAMPLE

    Immunohistochemical analysis of paraffin embedded human cancer tissue labelled with HCS-S310 at 1/1000 dilution.
    Perform heat mediated antigen retrieval with Tris/EDTA buffer pH 9.0 before commencing with IHC staining protocol.

Customer Reviews
Writing Reviews

Recent Advances

 
Drug Development Progress
  • English Name:

    Tumor-associated calcium signal transducer 2

  • Category:

  • Approved Drugs:

    3 Details

  • Drugs in Clinical Trials:

    25 Details

  • Highest Development Stage:

    Approved

Drug Candidate Licensing
More
  • Basic Product Information
  • Product Details
  • Customers Also Viewed
  • Performance Data
  • Customer Reviews